Abstract
Bush Administration Asks for Authority to Approve Generic Biologics; U.K. to Require Earlier Release of Adverse Trial Data; FDA Plans More Communication on Drug Risks; FDA Sets Out Rules for Distribution of Papers on Unapproved Uses; Grassley Asks GAO to Probe FDA Approvals; Supreme Court Splits on Rezulin Question; Medical Device Amendments Shield Manufacturers; PDUFA Deadlines Associated with More Approvals
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
